openPR Logo
Press release

Global Blue Biotechnology Market is expected to grow at CAGR 11.3% between 2018-2025 | Sheer Analytics and Insights

09-13-2018 08:53 PM CET | Health & Medicine

Press release from: Sheer Analytics and Insights Pvt. Ltd.

Global Blue Biotechnology Market is expected to grow at CAGR 11.3% between 2018-2025

Global Blue Biotechnology Market is expected to grow at CAGR 11.3% between 2018-2025

Global Blue Biotechnology market in terms of revenue is expected to grow at 11.3% CAGR between 2018 to 2025 as per new market research report titled Global Blue Biotechnology Market (by product type- pharma, biofuels, food, enzymes, biopolymers, and others. By application-vaccine development, drug finding, genomics, and others. By end-user-pharmaceutical companies, biotechnology companies, research organization, health care center, and others) – Global industry analysis, size, share, growth, trends, and forecast, 2018 – 2025, by Sheer Analytics & Insights Pvt. Ltd.

The blue biotechnology market is growing rapidly and it is mostly used in the healthcare and pharmaceutical sector. The products of blue biotechnology is also used for different types of treatment such as bones, antiviral, and wounds, and uncontaminated among others. Therefore, in the coming years it is estimated the global blue biotechnology will witness a upsurge in the market.

Read Full Report @ https://www.sheeranalyticsandinsights.com/market-report-research/global-blue-biotechnology-market-21

Moreover, the blue biotechnology market is creating ample opportunities in the field of sea monitoring. The market growth is also getting influenced globally by the research and development as the key players as they are manufacturing new kinds of products that consist of drug finding and enzymes. Recently, the major factors that are highly inducing the growth of the global blue biotechnology are the rapid development of new aquatic technologies that was used to monitor the sea atmosphere which was coupled with the surge of algae-derived bioenergy development and the high demand of marine renewable energy.

A considerable growth has been witnessed in the terms of research in the blue biotechnology segment. Currently, a team of biologists and researchers from the NYU Abu Dhabi has collaborated with the UAE University for conducting some of the researchers that will allow them to grow food-producing and the critical algae under conditions that were thought to be inhabitable for these kind of micro-organisms. According to the lead researcher, Weiqi Fu, Ph.D., Research Scientist, NYU Abu Dhabi, “With this technology, algae can be grown in photo-bioreactors at a higher density and a faster pace, reducing cost and speeding up production.”

Download report sample @ https://www.sheeranalyticsandinsights.com/request-sample/2/1/155/5

In addition to this, the huge number of blue biotechnology products in the regions of North America is making them the holder of largest market share in the blue biotechnology market. Moreover, the market growth is augmenting in the countries such as France, Germany, U.S., and in Italy as the focus on marine technology for the research and development of new drugs have increased. The continuous growth in the marine-based organisms such as algae, and bacteria in countries such as Chile, Brazil is increasing the demand for the blue biotechnology products in the regions of Africa and Middle East. Europe is the second largest market of blue biotechnology owing to their high demand for the marine products in this region. In the Asia Pacific region, China has a stable growth in the market of blue biotechnology as in India there is less application of this market.

The market research reports that is published by Sheer Analytics & Insights on Global blue biotechnology market, it has been segmented based on the product type, end-user, and application. Based on product type the market is segmented by biofuels, biopolymers, pharma, enzymes, and food. Based on their application it is segmented into drug finding, vaccine development, genomics, and others. There are also various other end-users who uses the blue biotechnology that consists of biotechnology companies, heath care centre, pharmaceutical companies, research organizations, and others. Moreover, the market is also segmented geographically into Middle East & Africa, North America, Europe, Asia Pacific, and Latin America.

Request a report brochure @ https://www.sheeranalyticsandinsights.com/request-brochure/2/1/155/2

Marine ingredient product was launched by Marinova such as Maritech fucoidan. This product is used to boost the immune cells and for reduction of the allergic responses. However, the latest studies have shown that this product also have the capacity to kill cancer cells directly and thus is expected that it will drive the blue biotechnology market in the foreseeable period.

The major companies in GlobalBlue Biotechnology market are as follows, Aker Biomarine, GeoMarine Biotechnologies, GlycoMar, New England Biolabs, Pml Application Ltd., Sea Run Holdings, Inc., Shell Marine Products, and Samudra Biopharma Private Limited among others.

Global Blue Biotechnology Market: By Product Type
• Pharma
• Biofuels
• Food
• Enzymes
• Biopolymers
• Others

Global Blue Biotechnology Market: By Application
• Vaccine development
• Drug finding
• Genomics
• Others

Global Blue BiotechnologyMarket: By End- User
• Pharmaceutical companies
• Biotechnology companies
• Research organization
• Healthcare Centre
• Others

Global Blue Biotechnology Market: By Geography
North America
• U.S.
• Canada
• Mexico
Europe
• U.K.
• France
• Germany
• Italy
• Rest of Europe
Asia Pacific
• India
• China
• Japan
• Rest of Asia Pacific
Middle East and Africa
• South Africa
• Rest of the Middle East and Africa
Latin America
• Brazil
• Rest of Latin America

Table of content:
1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS
2 EXECUTIVE SUMMARY
2.1 GLOBAL BLUE BIOTECHNOLOGY MARKET
3 GLOBAL BLUE BIOTECHNOLOGY MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL BLUE BIOTECHNOLOGY MARKET SNAPSHOT
4 GLOBAL BLUE BIOTECHNOLOGY MARKET OVERVIEW- BYPRODUCT TYPE
4.1 INTRODUCTION
4.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE
4.1.1.1 PHARMA
4.1.1.2 BIOFUELS
4.1.1.3 FOOD
4.1.1.4 ENZYMES
4.1.1.5 BIOPOLYMERS
4.1.1.6 OTHERS
5 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY APPLICATION
5.1 INTRODUCTION
5.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY APPLICATION
5.1.1.1 VACCINE DEVELOPMENT
5.1.1.2 GENOMICS
5.1.1.3 DRUG FINDING
5.1.1.4 OTHERS
6 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY END- USER
6.1 INTRODUCTION
6.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY END- USER
6.1.1.1 PHARMACEUTICAL COMPANIES
6.1.1.2 BIOTECHNOLOGY COMPANIES
6.1.1.3 RESEARCH ORGANIZATION
6.1.1.4 HEALTHCARE SECTOR
7 GLOBAL BLUE BIOTECHNOLOGY MARKETREVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
7.1 INTRODUCTIO
7.2 KEY TAKEWAYS
8 NORTH AMERICABLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
8.1 MARKET DYNAMICS
8.1.1 DRIVERS
8.1.2 RESTRAINTS
8.1.3 OPPORTUNITIES
8.2 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BYPRODUCT TYPE
8.3 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION
8.4 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
8.5 U.S.
8.6 CANADA
8.7 MEXICO
9 EUROPEBLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE
9.3 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION
9.4 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
9.5 U.K.
9.6 FRANCE
9.7 GERMANY
9.8 ITALY
9.9 SPAIN
9.10 REST OF EUROPE
10 ASIA PACIFICBLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS
10.1.3 OPPORTUNITIES
10.2 ASIA PACIFICBLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE
10.3 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION
10.4 ASIA PACIFICBLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
10.5 INDIA
10.6 CHINA
10.7 JAPAN
10.8 REST OF ASIA PACIFIC
11 MIDDLE EAST AND AFRICA(MEA) BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
11.1 MARKET DYNAMICS
11.1.1 DRIVERS
11.1.2 RESTRAINTS
11.1.3 OPPORTUNITIES
11.2 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE
11.3 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION
11.4 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
11.5 SOUTH AFRICA
11.6 REST OF MIDDLE EAST AND AFRICA
12 LATIN AMERICABLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
12.1 MARKET DYNAMICS
12.1.1 DRIVERS
12.1.2 RESTRAINTS
12.1.3 OPPORTUNITIES
12.2 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE
12.3 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BYAPPLICATION
12.4 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BYEND- USER
12.5 BRAZIL
12.6 REST OF LATIN AMERICA
13 COMPETATIVE LANDSCAPE
13.1 GLOBAL BLUE BIOTECHNOLOGY MARKET-COMPANY MARKET SHARE ANALYSIS
14 COMPANY PROFILES: (REVENUE, PRODUCTS/BRAND OFFERINGS, COMPANY HIGHLIGHTS)
14.1 AKER BIOMARINE
14.2 CELLGEN BIOLOGICALS PVT LTD.
14.3 DONALD DANFORTH PLANT SCIENCE CENTER
14.4 GEOMARINE BIOTECHNOLOGIES
14.5 GLYCOMAR
14.6 MARINOVA
14.7 NURTURE AQUA TECHNOLOGY PVT.
14.8 NEW ENGLAND BIOLABS
14.9 PICES
14.10 PML APPLICATION LTD.
14.11 SEA RUN HOLDINGS, INC
14.12 SHELL MARINE PRODUCTS
14.13 SANOSIL BIOTECH
14.14 SAMUDRA BIOPHARMA PRIVATE LIMITED

Important Tables and Figures:

LIST OF TABLES
TABLE 1 GLOBAL BLUE BIOTECHNOLOGY MARKET SIZE, 2017-2025 (USD MN)
TABLE 2 GLOBAL BLUE BIOTECHNOLOGY MARKET, BYPRODUCT TYPE
TABLE 3 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
TABLE 4 GLOBAL BLUE BIOTECHNOLOGY MARKET, BYEND- USER
TABLE 5 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET SIZE, 2017-2025 (USD MN)
TABLE 6 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET, BYPRODUCT TYPE
TABLE 7 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
TABLE 8 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET, BYEND- USER
TABLE 9 EUROPE BLUE BIOTECHNOLOGY MARKET SIZE, 2017-2025 (USD MN)
TABLE 10 EUROPE BLUE BIOTECHNOLOGY MARKET, BYPRODUCT TYPE
TABLE 11 EUROPE BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
TABLE 12 EUROPE BLUE BIOTECHNOLOGY MARKET, BYEND- USER
TABLE 13 ASIA-PACIFIC BLUE BIOTECHNOLOGY MARKET SIZE, 2017-2025 (USD MN)
TABLE 14 ASIA-PACIFIC BLUE BIOTECHNOLOGY MARKET, BYPRODUCT TYPE
TABLE 15 ASIA-PACIFIC BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
TABLE 16 ASIA-PACIFIC BLUE BIOTECHNOLOGY MARKET, BYEND- USER
TABLE 17 MIDDLE EAST AND AFRICA BLUE BIOTECHNOLOGYMARKET SIZE, 2017-2025(USD MN)
TABLE 18 MIDDLE EAST AND AFRICA BLUE BIOTECHNOLOGY MARKET, BYPRODUCT TYPE
TABLE 19 MIDDLE EAST AND AFRICA BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
TABLE 20 MIDDLE EAST AND AFRICA BLUE BIOTECHNOLOGY MARKET, BYEND- USER
TABLE 21 LATIN AMERICA BLUE BIOTECHNOLOGYMARKET SIZE, 2017-2025 (USD MN)
TABLE 22 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET, BYPRODUCT TYPE
TABLE 23 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
TABLE 24 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET, BYEND- USER

LIST OF FIGURES
FIGURE 1 MARKET SEGMENT
FIGURE 2 MARKET INTEGRATED ECOSYSTEM
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 6 EUROPE BLUE BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE 7 ASIA-PACIFIC BLUE BIOTECHNOLOGYMARKET SNAPSHOT
FIGURE8 MIDDLE EAST AND AFRICABLUE BIOTECHNOLOGY MARKET SNAPSHOT
FIGURE9 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET SNAPSHOT

Sheer Analytics and Insights Pvt. Ltd. is among the leading market research organizations providing the best B2B researches on various niches. Currently servicing 2000+ clients worldwide, our analysts and marketing team are continually tracking global markets having high growth prospect.

Sheer Analytics and Insights Pvt. Ltd.
Registered office:
RDB Boulevard,
8th Floor,
Plot K 1,
Sector 5, Block EP and GP,
Kolkata 700091, India.
Contact Number: +913346009199
Email Address: sales@sheeranalyticsandinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Blue Biotechnology Market is expected to grow at CAGR 11.3% between 2018-2025 | Sheer Analytics and Insights here

News-ID: 1238135 • Views: 1341

More Releases from Sheer Analytics and Insights Pvt. Ltd.

Osteoarthritis Market Size, Share, Growth, Analysis By Type, By Treatment, By Di …
According to a global Osteoarthritis Market report, published by Sheer Analytics and Insights, The Global Osteoarthritis Market was valued at $250 billion in 2020. Growing at a high CAGR of 12.7% between 2021 and 2031, it is estimated to reach $930 billion by 2031. Asia-Pacific region is anticipated to be the most lucrative destination for osteoarthritis surgical treatment in terms of market share. The revenue generation from this region is expected
Global Bronchial Thermoplasty market expected to reach US$ 99.68 Bn by 2026: Mar …
Sheer Analytics and Insights Pvt. Ltd. have published a report on the global Bronchial Thermoplasty market titled Global Bronchial Thermoplasty Market (By Age Group: 18-30 years, 30-50 years, and Greater than 50 years. By Regions: North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018 – 2026. The market is estimated to reach US$ 99.68 Bn by the
Global cell-based assay market expected to grow at 9% CAGR between 2017 and 2025 …
Sheer Analytics and Insights Pvt. Ltd. has published a report on the global Cell-Based Assay market titled Global Cell-Based Assay Market (By Product Type: Assay kits, Instruments, Reagents, Software and Services. By Application- Toxicology, ADME Studies and Drugs Discovery, By End-user- Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations and By Regions) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025. The market is
Global bioinformatics market expected to grow at 13.20% CAGR between 2018 and 20 …
Sheer Analytics and Insights Pvt. Ltd. has published a report on the global bioinformatics market titled Global Bioinformatics Market (By Products and Services: - Knowledge Management Tools, Bioinformatic Services and Bioinformatics Platform. By Application- Chemoinformatic, Genomics, Proteomics, Transcriptomics, Metabolomics and Others, By End-user- Pharmaceuticals, Education, Forensic, Environment and Others and By Regions) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025. The market is estimated to

All 5 Releases


More Releases for BIOTECH

Global Acetaminophen (Paracetamol) Market 2020 | Genesis Biotech, M.M. Pharma, A …
The Global Acetaminophen (Paracetamol) Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The study provides company profiling, product picture and specifications, sales, market share and contact information of key manufacturers of Global Acetaminophen (Paracetamol) Market.The Key manufactures involved in this market
Global Phycobiliprotein Market 2017 Norland Biotech, Algapharma Biotech, Phyco-B …
Global Phycobiliprotein Market Report 2017 Phycobiliprotein industrial chain, this report mainly elaborate the definition, types, applications and major players of Phycobiliprotein market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the
GLOBAL PHYCOBILIPROTEIN MARKET- DAINIPPON INK AND CHEMICALS, PHYCO-BIOTECH 2 COL …
Global Industry Study Evaluate on Phycobiliprotein Market by Type Manufacturers Regions and Application Forecast up to 2022 The scope of the Phycobiliprotein Report: This report primarily focuses on Phycobiliprotein in the global market. This report generally covers Phycobiliprotein market in North America Phycobiliprotein market in Asia-Pacific Phycobiliprotein market in Europe Phycobiliprotein market in Latin America Middle as well as Africa. This report partitions the Phycobiliprotein market based on Application Manufacturers Countries as
Harver Group Targets BioTech Bull
Synta Pharmaceuticals has a bullish outlook for Q3-Q4; insider buying indicates the company will be releasing positive research results and see a gain in returns. Jul. 24, 2013 - CHUO-KU, Japan -- Due to the huge increase in staff and board members buying stock in Synta Pharmaceuticals, and the successful trials of Synta Pharmaceuticals latest cancer drug Ganetespib, Pharmaceutical Analysts at Harver Group are now strongly recommending the stock as a
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Biotech APIs Showing Insurgent Growth
According to a new research report by RNCOS entitled, “Global Biotech API Market Analysis”, the rapidly growing and innovating biopharmaceuticals and biotechnology industry as a whole is putting the biotech API industry into charts of insurgent growth. Research Analysis & Highlights The report, “Global Biotech API Market Analysis”, spread over 55 pages, provides an in-depth research and rational analysis of the current and expected status of the biotech API industry across the